The Congress brings together distinguished speakers around the world with the aim to improve levels of clinical and basic research on diabetes in the region. These include:-
 |
- Mobile connectivity and diabetes eHealth
- "Actionable" SMBG for patients using insulin |
 |
Emerging data about ARNT and other transcription factors in gene expression and islet dysfunction in type 2 diabetes and gestational diabetes |
David Kerr, MD, FRCPE
Director of Research and Innovation
William Sansum Diabetes Center |
Jenny Gunton
Chair of Medicine, University of Sydney, Westmead Hospital
President, Australian Diabetes Society |
 |
- The usefulness of glucose and lipid control in nephropathy and retinopathy
- Using HbA1c to diagnose diabetes is neither helpful, nor is it accurate |
 |
An Asian diabetes phenotype, or a phenotype in transition?
Juliana Chan
Chair Professor, Department of Medicine and Therapeutics
Director, Hong Kong Institute of Diabetes and Obesity
Co-director, IDF Centre of Education, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong
|
Jonathan Shaw
Associate Director
Health Services of Baker IDI Heart and Diabetes Institute |
 |
- The evolving paradigm in T2DM treatment with contemporary and complimentary therapeutic strategies
- DPP4 inhibitors: the CV outcomes trials
|
 |
National diabetes care models: perspective from ASEAN countries |
Lawrence A. Leiter, MD, FRCPC, FACP, FAHA
Professor of Medicine and Nutritional Sciences,
University of Toronto |
Pongamorn Bunnag
Assistant Professor
Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine
Ramathibodi Hospital, Mahidol University |
 |
Type 1 diabetes mellitus in preschool children
Ragnar Hanas, MD, PhD
Associate Professor
The Sahlgrenska Academy
University of Gothenburg
Institute of Clinical Sciences
|
 |
- Optimising glycemic control to protect renal and cardiovascular complications of type 2 diabetes- Findings from ADVANCE-ON
- National diabetes care models: perspective from ASEAN countries |
Siew Pheng Chan, MBBS (Malaya), FRCP (Edinburgh), AM (Malaya)
Visiting Professor
Senior Consultant Endocrinologist
Endocrine Unit, Department of Medicine
University of Malaya Medical Centre, Kuala Lumpur, Malaysia |
 |
- Ethnic differences in genome-wide association studies
- Is diabetes truly still a coronary artery disease equivalent? |
 |
- The epigenome and its role in diabetes
- Adipose tissue inflammation and B regulatory cell dysfunction
|
Tai E Shyong
Senior consultant, National University Hospital
Associate Professor, Yong Loo Lin School of Medicine and Saw Swee Hock School of Public Health, National University of Singapore
Associate Professor, Duke-National University of Singapore Graduate Medical School |
Takashi Kadowaki, MD, PhD
Professor of Diabetes and Metabolic Diseases
University of Tokyo |
 |
- Epidemic obesity and the rise of type 2 diabetes in Asia
- DPP-4 Inhibitors: Have We Optimized Their Role in the Treatment of Patients With Type 2 Diabetes? |
 |
Adiponectin, FGF21 and metabolic homeostasis |
Yoon Kun-Ho
Professor of Department of Endocrinology and Metabolism,
Seoul St. Mary’s Hospital, The Catholic University of Korea |
Xu Aimin, PhD, MD
Professor of Medicine,
Director of State Key Laboratory of Pharmaceutical Biotechnology,
The University of Hong Kong |